Labcorp Holdings Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +7.3%
EBITDA: +13.9%
EBIT: +43.0%
EPS: +30.4%
Free cash flow: +20.1%
Operating cash flow: +11.0%

Forward estimates

Revenue: +5.9%
EBITDA: +21.9%
EPS: +62.8%

Three-year CAGR

Revenue: +5.6%
EBITDA: +1.0%
EBIT: +1.8%
Net income: -11.8%
EPS: -9.1%
Free cash flow: -6.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.